Craneware (LON:CRW) Hits New 12-Month Low – Should You Sell?

Craneware plc (LON:CRW)’s share price hit a new 52-week low on Friday . The company traded as low as GBX 1,355 and last traded at GBX 1,375, with a volume of 183074 shares traded. The stock had previously closed at GBX 1,385.

Analysts Set New Price Targets

CRW has been the topic of a number of recent analyst reports. Berenberg Bank reissued a “buy” rating and issued a GBX 2,900 price objective on shares of Craneware in a research note on Tuesday, January 20th. Shore Capital Group reaffirmed a “buy” rating and issued a GBX 2,850 target price on shares of Craneware in a report on Tuesday, January 20th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Craneware presently has an average rating of “Buy” and an average target price of GBX 2,873.67.

Craneware Stock Performance

The firm has a market capitalization of £488.25 million, a price-to-earnings ratio of 24.91 and a beta of 0.28. The company has a current ratio of 0.76, a quick ratio of 1.00 and a debt-to-equity ratio of 7.93. The stock’s 50-day moving average is GBX 1,650.25 and its 200-day moving average is GBX 1,992.45.

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.